Deloitte: Open Innovation Success Rate 3 Times Higher Than In-house R&D

By • on October 8, 2016

The Knowledge website reported that the knowledge intensity and speed of biotechnology has shifted the locus of innovation to a network rather than within any single firm. This is causing pharmaceutical firms to look for new ways to tap into innovative sources of drug development outside their organizational boundaries and they are increasingly engaging in “open innovation.” Open innovation appears to increase R&D effectiveness. According to a study by Deloitte, the success of drug candidates sourced through open innovation is approximately three times higher than those sourced through in-house R&D.

Click here to read the full article.

Image via Flickr.

Related Posts

Related Entries

Recent Entries

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.